This article is more than 5 years old. Information may no longer be current.
Infectious Diseases in Children Symposium welcomes some new faces, features latest information on ID issues
Click Here to Manage Email Alerts
This month, the Infectious Diseases in Children Symposium in New York City welcomes its first new course director in 23 years, David W. Kimberlin, MD, who promises that this year’s meeting will continue to feature all of the latest information on vaccines and upcoming treatment modalities that long-time course-goers have come to trust.
Kimberlin, who is a professor of pediatrics and co-director in the division of pediatric infectious diseases at the University of Alabama at Birmingham, replaces Philip Brunell, MD, who retired last fall.
“This is an exciting time, and I look forward to seeing everyone the weekend before Thanksgiving in New York City as we embrace these new opportunities,” Kimberlin said.
The meeting, which will be held Saturday and Sunday, Nov. 20-21 at the New York Marriott Marquis in Manhattan, will feature expert faculty who will address the latest recommendations for vaccine administration, discuss new treatment modalities for managing emerging diseases and review the latest clinical data on treatments for respiratory illnesses. The meeting will also feature traditional favorites, including the popular What’s Your Diagnosis feature from James H. Brien, DO.
On Saturday, Infectious Diseases in Children Editorial Board member Paul A. Offit, MD, will address the issue of parents that refuse vaccinations. Some physicians have taken the stance of refusing to see these patients. Other pediatricians have taken more of an advisory approach.
“Pediatricians are in a tough spot, whether they decide to only see patients who choose to use the recommended CDC and AAP schedule or whether they try to cater to the parents’ chosen vaccine schedule, neither of those approaches is perfect,” Offit said, adding that his discussion will focus on both sides of the issue and look at data that show which approaches work best.
Penelope H. Dennehy, MD, of Hasbro Children’s Hospital, will also discuss vaccines, including the latest information on the measles-mumps-rubella and varicella vaccine, and information on the pneumococcal and human papillomavirus vaccines. Also, Anne A. Gershon, MD, of Columbia University, will test your diagnostic skills with her talk, “Vaccine-Preventable Diseases, Would You Know One If (Or When) You See It?”
Continuing on the agenda for Saturday morning, H. Cody Meissner, MD, from Tufts University School of Medicine, will discuss the recent modifications to the respiratory syncytial prophylaxis guidelines. Major changes in the recommendations for immunoprophylaxis of infants with a gestational age between 32 weeks and 35 weeks are contained in the AAP’s Committee on Infectious Disease report, and Meissner will discuss why these changes were made.
Also on Saturday morning, C. Mary Healy, MD, from Baylor College of Medicine in Houston, will weigh in on preventing perinatal infections.
On Saturday afternoon, Infectious Diseases in Children Editorial Board member Stan L. Block, MD, will discuss antibiotics and upper respiratory infections. The emergence of more antibiotic resistant bugs presents ongoing treatment challenges for the pediatrician, and Block will discuss when antibiotics should and should not be considered.
Also on Sunday, discussions will focus on urinary tract infections, reflux, fever and sexually transmitted infections in adolescents.
On Sunday, the discussion on infectious diseases will continue with a keynote lecture on influenza.
Influenza-associated deaths in children have also been reported and are highest in children younger than 6 months. The recent emergence of a pandemic novel influenza H1N1 strain (2009 H1N1) and its rapid worldwide spread have had an important effect on children, and Infectious Diseases in Children Editorial Board member Kathryn M. Edwards, MD, will address these issues.
Another Infectious Diseases in Children Editorial Board member, Joseph A. Bocchini Jr., MD will discuss the recent recommendations from the AAP on head lice. A revised clinical report issued recently from the AAP clarifies and updates protocols for diagnosis and treatment and provides guidance for the management of head lice in the school setting.
AAP officials said in the report that no healthy child should be excluded from or miss school because of head lice, and “no-nit” policies for return to school should be abandoned. Bocchini, who co-authored the report, will discuss why the guidance was issued, and will also discuss scabies management.
Other discussions in the morning will focus on rickettsial diseases, Lyme disease management and office-based point-of-care lab testing.
The afternoon discussions on Sunday will focus on treating infectious diseases, including a discussion by Infectious Diseases in Children Editorial Board member Sheldon L. Kaplan, MD, titled “MRSA Issues: Where Are We 10 Years Into the Epidemic?”
Also on Sunday, discussions will focus on antibiotic-associated diarrheas, antifungals, and treating outpatient pneumonias.
The meeting will also feature special CME seminars on pediatric respiratory diseases, HPV and pediatric conjunctivitis. Each discussion will focus on the clinical significance of the research data being presented, and how to implement these new advances into your own practice.
The Marriott Marquis is conveniently located near Midtown attractions such as Carnegie Hall, Lincoln Center, the United Nations and Madison Square Garden.
For additional information, please visit the website at www.idcnewyork.com or call 877-307-5225, ext. 219 or 476.